Check out our most popular compounded medications! Get Started
Ondansetron 20 mg/ml Topical Gel is a semisolid formulation dispensed through a pump mechanism. This allows for easy and precise application on the skin, providing targeted treatment for conditions such as nausea, vomiting, gastroesophageal reflux disease, motion sickness, and chemotherapy-induced nausea and vomiting. The gel-like consistency aids in the absorption of the active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Ondansetron 20 mg/ml Topical Gel is a specially compounded medication designed to treat a range of disease states. This semisolid formulation is dispensed through a pump mechanism, ensuring easy and precise application directly onto the skin.
Aside from its antiemetic properties, Ondansetron 20 mg/ml Topical Gel is also used in the treatment of gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and other gastrointestinal disorders. It provides relief from a variety of symptoms including nausea, vomiting, abdominal pain, and bloating. The ease of application and the well-tolerated nature of this gel make it a preferred treatment option for many patients.
Its precise application and targeted treatment approach make it a valuable addition to the range of treatment options available for these conditions.
If you have any questions about Ondansetron 20 mg/ml Topical Gel or any other compounded medications, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you with your queries and concerns.
Ondansetron 20 mg/ml Topical Gel is a semisolid formulation designed for easy and precise application on the skin. It is primarily used for the treatment of nausea and vomiting associated with chemotherapy, radiation therapy, and postoperative recovery. However, it may also be prescribed for other conditions as determined by your healthcare provider.
It is important to note that this medication should not be used in patients with known hypersensitivity to ondansetron or any of the inactive ingredients in the formulation. Signs and symptoms of hypersensitivity reactions may include rash, pruritus, and urticaria. If any of these symptoms occur, patients should seek immediate medical attention.
Patients with hepatic impairment should use Ondansetron 20 mg/ml Topical Gel with caution, as the drug is metabolized by the liver. Regular monitoring for signs and symptoms of hepatic toxicity, such as jaundice, dark urine, and abdominal pain, is recommended.
Similarly, patients with renal impairment should exercise caution when using this medication, as the drug is eliminated by the kidneys. Regular monitoring for signs and symptoms of renal toxicity, including decreased urine output, increased serum creatinine, and increased blood urea nitrogen, is advised.
Patients with a history of seizures should also use Ondansetron 20 mg/ml Topical Gel with caution, as the drug may increase the risk of seizures. Signs and symptoms of seizures may include convulsions, confusion, and loss of consciousness. Regular monitoring for these symptoms is recommended.
If you have any questions or concerns about Ondansetron 20 mg/ml Topical Gel, please consult with your healthcare provider.
Ondansetron 20 mg/ml Topical Gel is a semisolid formulation designed for direct application on the skin. This medication is primarily used to alleviate nausea and vomiting associated with various medical treatments such as chemotherapy, radiation therapy, and certain medications like opioids. It can also be beneficial in managing nausea and vomiting induced by motion sickness.
The active ingredient, Ondansetron, works by blocking the action of serotonin, a neurotransmitter that can trigger nausea and vomiting. The gel is absorbed through the skin into the bloodstream, providing targeted treatment to the affected area. It is crucial to remember that this medication should not be applied on broken or irritated skin.
When using Ondansetron 20 mg/ml Topical Gel, it is essential to adhere to the instructions provided by your healthcare provider or pharmacist. The gel should be applied to the designated area as directed, avoiding contact with the eyes, nose, and mouth. In case of accidental contact, rinse the area thoroughly with water.
While Ondansetron 20 mg/ml Topical Gel is generally well-tolerated, it may cause side effects such as skin irritation, redness, or itching. If you experience any of these side effects, it is recommended to contact your healthcare provider or pharmacist for advice.
If you have any queries or concerns about Ondansetron 20 mg/ml Topical Gel, do not hesitate to reach out to your healthcare provider or pharmacist. They are equipped with the necessary knowledge and expertise to assist you with your medication needs.
Ondansetron 20 mg/ml Topical Gel is a versatile treatment option that has been utilized for a wide range of conditions. It has also been used to treat gastroesophageal reflux disease and motion sickness. The gel has shown efficacy in reducing the severity of opioid-induced pruritus, a common side effect of opioid use.
Furthermore, Ondansetron 20 mg/ml Topical Gel has been used to alleviate the discomfort of opioid withdrawal symptoms, such as anxiety, agitation, and restlessness. It has also been beneficial in reducing the severity of opioid-induced constipation, respiratory depression, and sedation. The gel has also been used to manage opioid-induced hyperalgesia and myoclonus.
Lastly, Ondansetron 20 mg/ml Topical Gel has been used to manage opioid-induced nausea and vomiting, further demonstrating its versatility in managing a variety of conditions related to opioid use. If you have any questions about the use of Ondansetron 20 mg/ml Topical Gel for any of these conditions, please do not hesitate to reach out.
Ondansetron 20 mg/ml Topical Gel is a semisolid formulation that is dispensed through a pump mechanism. It is designed for easy and precise application on the skin for targeted treatment or absorption of active ingredients.
Ondansetron 20 mg/ml Topical Gel works by delivering the active ingredient, Ondansetron, directly to the targeted area through the skin. The gel-like consistency allows for easy application and absorption.
You should apply the gel to the targeted area as directed by your healthcare provider. The pump mechanism allows for easy and precise application.
It is recommended to use Ondansetron 20 mg/ml Topical Gel only on the area directed by your healthcare provider. Avoid contact with eyes, mouth, and other sensitive areas.
If you miss a dose, apply it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and go back to your regular dosing schedule.
Side effects can vary from person to person. Some common side effects may include skin irritation at the application site. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Before using Ondansetron 20 mg/ml Topical Gel, inform your healthcare provider if you are pregnant, planning to become pregnant, or breastfeeding. They will be able to advise you on the best course of action.
Before starting any new medication, including Ondansetron 20 mg/ml Topical Gel, it is important to discuss with your healthcare provider about all the medications you are currently taking, including over-the-counter drugs and supplements.
Ondansetron 20 mg/ml Topical Gel should be stored at room temperature, away from heat and direct light. Do not freeze the medication, and keep it out of reach of children and pets.
If you suspect an overdose, seek immediate medical attention or call your local poison control center. Symptoms of an overdose may include severe skin irritation or rash.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
